Uncategorized
Eyevensys Presents Initial Data from Phase I/II Trial of Innovative, Non-Viral Gene Therapy for Ocular Diseases at 11th Annual Ophthalmology Innovation Summit
SAN FRANCISCO--(BUSINESS WIRE)-- #OIS2019--Eyevensys presented initial results from a phase I/II trial of its innovative, non-viral gene therapy for ocular diseases at OIS@AAO this week.